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Abstract
Background: Ucp3 is an integral protein of the inner mitochondrial membrane with a role in lipid
metabolism preventing deleterious effects of fatty acids in states of high lipid oxidation. Ucp3 is
expressed in brown adipose tissue and skeletal muscle and controlled by a transcription factor
complex including PPARalpha, MyoD and the histone acetyltransferase p300. Several studies have
demonstrated interaction of these factors with chicken ovalbumin upstream promoter
transcription factor II (Coup-TFII). This nuclear receptor is involved in organogenesis and other
developmental processes including skeletal muscle development, but also co-regulates a number of
metabolic genes. In this study we in silico analyzed the upstream region of Ucp3 of the Djungarian
hamster Phodopus sungorus and identified several putative response elements for Coup-TFII. We
therefore investigated whether Coup-TFII is a further player in the transcriptional control of the
Ucp3 gene in rodents.
Results: By quantitative PCR we demonstrated a positive correlation of Coup-TFII and Ucp3 mRNA
expression in skeletal muscle and brown adipose tissue in response to food deprivation and cold
exposure, respectively. In reporter gene assays Coup-TFII enhanced transactivation of the Ucp3
promoter conveyed by MyoD, PPARalpha, RXRalpha and/or p300. Using deletions and mutated
constructs, we identified a Coup-TFII enhancer element 816–840 bp upstream of the
transcriptional start site. Binding of Coup-TFII to this upstream enhancer was confirmed in
electrophoretic mobility shift and supershift assays.
Conclusion: Transcriptional regulation of the Coup-TFII gene in response to starvation and cold
exposure seems to be the regulatory mechanism of Ucp3 mRNA expression in brown adipose and
skeletal muscle tissue determining the final appropriate rate of transcript synthesis. These findings
add a crucial component to the complex transcriptional machinery controlling expression of Ucp3.
Given the substantial evidence for a function of Ucp3 in lipid metabolism, Coup-TFII may not only
be a negative regulator of glucose responsive genes but also transactivate genes involved in lipid
metabolism.
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Uncoupling protein 3 (Ucp3) is a member of the family of
uncoupling proteins, which are located in the inner mito-
chondrial membrane and uncouple the respiratory chain
from ATP synthesis by dissipating the proton motive force
[1,2]. The physiological function of Ucp3 is subject to an
ongoing debate [3]. Regulation of Ucp3 expression sug-
gests a role in lipid metabolism. Skeletal muscle Ucp3
transcription is increased in response to food deprivation,
a robust mechanism consistently observable in man,
rodents and even fish [4]. Further physiological condi-
tions positively regulating Ucp3 include cold exposure
[5,6], acute exercise [7] and streptozotocin-induced diabe-
tes [8]. Increased levels of circulating free fatty acids (FFA)
are common to all these physiological states; infusion
experiments imply that these are the primary cause for
Ucp3 upregulation [9]. Therefore it has been suggested,
though not proven experimentally, that Ucp3 is a fatty
acid anion carrier [10].
The biochemical properties of the protein as measured in
mitochondrial proton leak assays by parallel recording of
membrane potential and oxygen consumption infer a role
for Ucp3 in the defense against radical oxygen species
(ROS), mitigating their generation by mild uncoupling
[11]. This possible function is corroborated by the finding
that a product of ROS induced lipid peroxidation, 4-
hydroxy-2-nonenal, specifically induces uncoupling by
Ucp3 and that even a small reduction of membrane
potential markedly decreases ROS production [12]. A con-
troversial hypothesis which takes into account both phys-
iological and biochemical data emphasizes that the export
of fatty acids or hydroperoxy fatty acids and subsequent
protonated re-influx of a certain fraction into the matrix
would result in a net proton import detectable as mild
uncoupling [13,14]. This mechanism would reduce ROS
production and at the same time reduce the level of non-
esterified fatty acids in the matrix susceptible to peroxida-
tion, thereby preventing deleterious effects in states of
high lipid oxidation.
Ucp3 is predominantly expressed in skeletal muscle
(SKM) and brown adipose tissue (BAT), both tissues with
exceptionally high lipid oxidation capacities. The princi-
pal molecular constituents of Ucp3 gene regulation have
recently been identified by several copious studies. Het-
erodimers of peroxisome proliferator activated receptor α
(PPARα) and the retinoic X receptor α (RXRα) bind to a
response element (PPRE) within the proximal promoter
region and activate transcription depending on the pres-
ence of myogenic differentiation antigen 1 (MyoD).
MyoD binds to a series of non-canonical E-boxes directly
adjacent to the transcriptional start site (TSS). Induction is
enhanced by the coactivator p300 protein (p300), which
acetylates MyoD and possibly surrounding histones [15].
Furthermore, the PPRE in the Ucp3 promoter is multifunc-
tional, i.e. can alternatively be targeted by heterodimers of
the thyroid hormone receptor (TR) and RXRα stimulating
expression in the presence of MyoD [16]. The ligands of
PPARα (fatty acids) and TRs (T3) along with the require-
ment of MyoD indicate that this mechanism is involved in
the acute response of Ucp3 expression in SKM to physio-
logical stimuli. However, to our knowledge neither BAT-
specific nor differentiation specific regulation has been
characterized in detail to date.
Notably several studies have demonstrated interaction of
PPARs, MyoD and/or p300 with chicken ovalbumin
upstream promoter transcription factor II (Coup-TFII,
official gene name: Nr2f2) [17-20]. This nuclear receptor
is involved in organogenesis and other developmental
processes [21] including SKM development [22], but also
co-regulates a number of metabolic genes [18,23-25].
In this study we analyzed the upstream region of Ucp3 of
the Djungarian hamster Phodopus sungorus in silico and
identified several putative response elements for Coup-
TFII. We therefore investigated whether Coup-TFII is a fur-
ther player in the transcriptional control of the Ucp3 gene
in rodents.
Results
Structure of the hamster Ucp3 gene
We successfully cloned the genomic Ucp3 locus of the
hamster. Primers to amplify fragments of the upstream
region (approx. -3500 to +50) were deduced from con-
served segments of corresponding rodent genomic
sequences. Resulting PCR products were sequenced and
served as a framework to select primers for gap closure.
We extended this contig to the putative 5' adjacent gene.
Ucp3 introns were amplified with exonic primers based on
the known hamster cDNA [GenBank: AF271265] and on
the exon 1 sequence obtained as described above. The
resulting genomic contig of 12,720bp included 3632 bp
of Ucp3 5' gene flanking region as well as all Ucp3 exons
and introns; the sequence of the terminal exon extends
210 bp 3' of the stop codon [GenBank: AY523564].
We identified two novel splice variants of the Ucp3 tran-
script in BAT [GenBank: DQ244043, DQ244044; not
shown]. One transcript is characterized by partial mobili-
zation of the second intron, presumably resulting in a pre-
mature stop [GenBank: DQ244044], the other lacks the
second exon, possibly leading to alternative usage of the
next in frame start codon wich is located in exon3 [Gen-
Bank: DQ244043].
In our 5' RACE analysis, the TSS was variable within a
range of 72 bp (Fig. 1). To determine a reference point for
relative sequence positions we arbitrarily chose positionPage 2 of 15
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obtained in BAT and SKM cDNA RACE experiments,
respectively. Of six additional sequenced clones, one con-
tained a start site at -49 (SKM), two at -20 (both BAT), one
at -3 (SKM), one at +16 (SKM) and at +23 (BAT). Thus the
TSS did not show a distinct tissue specificity.
Analysis of the UCP3 promoter
We compared rodent and human proximal promoter
sequences to classify promoter elements by their conser-
vation (Fig. 1). Of the elements recently characterized by
Solanes and coworkers (2003, 2004) – mediating tran-
scriptional activation by PPARα, TRs and MyoD – the
PPRE/TRE was located within a region that is identical in
the compared species. The 21 bp long MyoD-binding tri-
ple E-box only differs in three nucleotides of the first
repeat and is otherwise identical. In contrast, two TATA-
like boxes identified in the human promoter [26] are
absent in the known rodent sequences. By in silico analysis
of the hamster Ucp3 promoter we detected several puta-
tive nuclear receptor binding sites, among them 28 ele-
ments predicted to possibly bind Coup-TFII.
Sequencing of hamster Coup-TFII and qPCR
To derive homologous primers for qPCR we cloned and
sequenced a 325 bp fragment of Coup-TFII [GenBank:
DQ44042] comprising coding regions of exon 2 and 3.
Hamster sequences were 98% identical with the murine
orthologue. The deduced amino acid sequences of ham-
ster and mouse are identical. In a first experiment we
determined mRNA expression levels of Coup-TFII and
Ucp3 by qPCR analysis in a panel of nine tissues of ham-
sters housed under standard laboratory conditions and
fed ad libitum (Fig. 2). Ucp3 levels were highest in SKM
and BAT, much lower in heart and white adipose tissue
and virtually absent in all other tested tissues. Coup-TFII
was well detectable in all analyzed tissues with highest
amounts in kidney and SKM. The individual variation for
both Ucp3 and Coup-TFII was maximal in SKM. Ucp3
mRNA levels in BAT were about 50% of SKM expression,
interestingly the same is true for Coup-TFII.
To explore a possible coregulation of Ucp3 and Coup-TFII
we exposed hamsters to cold and food deprivation, phys-
iological challenges known to upregulate Ucp3 expression
[6,27] (Fig. 3A). In SKM food deprivation led to a signifi-
Alignment of the human and three rodent proximal Ucp3 promoter regionsFigure 1
Alignment of the human and three rodent proximal Ucp3 promoter regions. Positions of identical bases are marked 
(*). The PPRE/TRE (box) as well as the MyoD binding triple E-box (dashed box) are highly conserved. Two TATA-like boxes 
(bold) can only be found in the human promoter. Transcriptional start sites of P. sungorus were identified within a wide range 
(black background), the arbitrarily chosen reference TSS is indicated (#). Rn = R. norvegicus, Mm = M. musculus, Ps = P. sungorus, 
Hs = H. sapiensPage 3 of 15
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exposed hamsters Ucp3 was not systematically upregu-
lated but displayed an increased individual variation. A
similar degree of variation without significant cold-
induced regulation was observed for Coup-TFII. To test for
a possible coregulation we measured Ucp3 and Coup-TFII
transcript abundancies and compared respective levels of
control and challenged animals (Fig. 3B and 3C). Under
control conditions no correlation was observed. However,
we detected a highly significant correlation (r2 = 0.834, p
< 0.001) between Ucp3 and Coup-TFII levels in challenged
animals.
Luciferase reporter gene assays with cotransfected 
transcription factors
We tested Coup-TFII in cotransfection reporter gene assays
with regard to its potential in coactivating a Ucp3 pro-
moter fragment of 2244 bp cloned into the luciferase
reporter gene vector pGL3basic (-2244Ucp3luc). To evalu-
ate the influence of Coup-TFII we compared cotransfec-
tions with or without expression vectors for PPARα,
MyoD, RXRα and/or the histone acetyltransferase p300,
factors known to regulate Ucp3 expression [15] (Fig. 4A).
Without Coup-TFII none of the tested factors upregulated
-2244Ucp3luc more than 5-fold. Cotransfection of several
factors exhibited a synergistic effect, which was aug-
mented by p300, e.g. adding RXRα to MyoD hardly
increased reporter gene activity, but in the presence of
Expression level of Coup-TFII and Ucp3 mRNA in tissues of P. sungorusFigure 2
Expression level of Coup-TFII and Ucp3 mRNA in tissues of P. sungorus. Coup-TFII mRNA is expressed in all examined 
tissue types as measured by qPCR. Ucp3 mRNA is found together with Coup-TFII mRNA in BAT and SKM. Both display highest 
variability in SKM (SKM/BAT n = 9, other tissues n = 3). Black dots represent individual results, bars are mean values. WAT = 
white adipose tissue, SKM = skeletal muscle, BAT = brown adipose tissue.Page 4 of 15
(page number not for citation purposes)
BMC Molecular Biology 2007, 8:1 http://www.biomedcentral.com/1471-2199/8/1p300 notably induced expression. The strongest induction
(47-fold) was achieved by a cotransfection of PPARα,
MyoD and p300 in the presence of the synthetic PPARα
agonist Wy14,643.
Cotransfection of Coup-TFII systematically increased
reporter gene expression in all combinations tested.
Together with a single other factor it was particularly effec-
tive with MyoD or p300, attaining an additional 3–5 fold
induction. In combination with multiple factors Coup-
TFII cotransfection consistently led to an approximate
doubling of induction. The maximal induction in com-
parison to the basal construct activity was achieved in
combination with RXRα, MyoD and p300 (95-fold),
which is two fold higher than the maximal level observed
in any experiment without Coup-TFII (ligand-activated
PPARα + MyoD + p300, 47-fold). The dimension of
induction by Coup-TFII is illustrated by comparison with
the PPARα activation through the ligand Wy14,643 on a
background of PPARα, MyoD and p300. Here transactiva-
tion by Coup-TFII and the ligand Wy14,643, respectively,
is in the same order of magnitude.
To exclude that overexpression of any nuclear receptor or
Coup-TF family member unspecifically leads to an induc-
tion of the Ucp3 promoter we utilized an expression vector
for Coup-TFI, which is a close Coup-TFII relative sharing
85.5% of identical amino acid sequence, as a control.
Replacing Coup-TFII by Coup-TFI in cotransfections with
transcription factor combinations did not lead to activa-
tion of the Ucp3 promoter, but conversely downregulated
reporter gene activity (Fig. 4A), possibly due to competi-
tion for RXRα. We therefore conclude that Coup-TFII spe-
cifically transactivated the Ucp3 promoter in synergy with
other known transcription factors and coactivators.
To locate the responsible cis element, we studied the
potential of Coup-TFII to activate several reporter gene
deletion constructs (Fig. 4B). Coup-TFII transfection
alone in this assay increased luciferase activity on -
2244Ucp3luc 16-fold while all other constructs are much
less sensitive. There is, however, a certain unspecific effect
on the empty pGL3 basic vector, that can also be seen for
all constructs used. This handicap was absent when we
cotransfected the deletion constructs with MyoD, RXRα
and p300, the combination exhibiting the strongest effect
on -2244Ucp3luc. The Coup-TFII effect is limited to -
2244Ucp3luc, locating the crucial region between nucle-
otides -1307 to -664, which are exclusively found on this
construct. We identified several possible binding sites for
Coup-TFII in this fragment: -1269 (A), -901 (B), -837 and
-827 (C), -807 (D) and -779 (E).
Electrophoretic mobility shifts assays
We tested five oligonucleotide probes corresponding to
the putative response elements A-E (see above) for bind-
ing of Coup-TFII in electrophoretic mobility shift assays.
Elements A, B, D and E did not display any specific inter-
action (Fig. 5A). For element C we were able to show a
strong complex formation in the presence of Coup-TFII,
Response of Coup-TFII and Ucp3 mRNA expression to physiological challenges inducing lipid utilizationFigure 3
Response of Coup-TFII and Ucp3 mRNA expression to physiological challenges inducing lipid utilization. (A) 
Expression of Coup-TFII and Ucp3 mRNA in BAT of cold exposed and SKM of food deprived hamsters as compared to control 
conditions. Shown are mean values with standard error, * = p < 0,05. (B) Relationship of Ucp3 and Coup-TFII mRNA levels in 
SKM and BAT of hamsters housed under standard conditions with ad libitum access to food; r2 = 0.211, p = not significant (SKM 
n = 9, BAT n = 9). (C)Correlation of Ucp3 and Coup-TFII mRNA abundancies in SKM of food deprived and BAT of cold 
exposed animals; r2 = 0.834, p < 0.001 (SKM n = 9, BAT n = 9).Page 5 of 15
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Coup-TFII transactivates the Ucp3 promoter in cotransfection reporter gene assaysFig re 4
Coup-TFII transactivates the Ucp3 promoter in cotransfection reporter gene assays. (A) Activity of reporter gene 
construct -2244UCP3luc in cotransfection experiments with various transcription factors (fold change relative to basal -
2244UCP3luc level). Coup-TFII coactivates the Ucp3 promoter in all combinations. It is especially effective together with MyoD, 
RXRα and p300. Coup-TFI does not activate reporter gene expression demonstrating a specific effect of Coup-TFII. (B) Iden-
tification of the region mediating Coup-TFII transctivation by analysis of deletion reporter gene constructs. Shown in the upper 
panel is the basal activity and induction by Coup-TFII of all constructs, in the lower panel the experiment was repeated on a 
background of MyoD, RXRα and p300 (note the different axis scaling). The shaded area highlights the region that is exclusively 
found on -2244UCP3luc and is responsible for the Coup-TFII effect in both setups.
BMC Molecular Biology 2007, 8:1 http://www.biomedcentral.com/1471-2199/8/1that was specifically supershifted by the respective anti-
body. Binding of proteins to this probe was effectively
blocked by competition with the unlabelled oligonucle-
otide.
The antibody was specific for Coup-TFII and did not bind
the close relative Coup-TFI. Virtually all Coup-TFII was
detected in the nuclear fraction (Fig. 5B).
Nuclear extracts from skeletal muscle tissue of food
deprived (n = 3) and control (n = 3) hamsters were able to
form a bandshift on element C of comparable size. In two
Coup-TFII binds to a conserved element of the Ucp3 promoterFig re 5
Coup-TFII binds to a conserved element of the Ucp3 promoter. (A) Electrophoretic mobility shift assay with candi-
date probes A-E and nuclear extracts of HEK293 cells. Overexpression of Coup-TFII leads to formation of a specific complex 
on probeC only, that can be supershifted with a Coup-TFII antibody. All complexes are subject to competition with 100 fold 
molar excess of unlabelled probe C. (B) Western Blot of protein fractions of HEK293 cells with a Coup-TFII-antibody. Coup-
TFII is specifically detected in the nuclear fraction and absent in untransfected cells. M = Marker, - = mock transfected, CI = 
Coup-TFI transfected, CII = Coup-TFII transfected. (C) Alignment of the human and rodent promoter regions of the Ucp3 
gene (Ps: -821 to -857). The positions of identical bases are marked (*). The putatively Coup-TFII binding elements (box, 
dashed box) located on probe C are conserved in all rodent species. In the murine promoter they are found in reverse order 
slightly more upstream. The human promoter does not feature comparable sequences in the compared region. Rn = R. norvegi-
cus, Mm = M. musculus, Ps = P. sungorus, Hs = H. sapiens (D) Electrophoretic mobility shift assay with skeletal muscle nuclear 
extracts from control and food deprived hamsters. The complex shown is of a size comparable to the Coup-TFII complex 
above. Starvation induces complex formation in comparison to control conditions.Page 7 of 15
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than in control conditions (Fig. 5D).
The two elements present in oligonucleotide C form a
functional repeat as is typical for binding sites of nuclear
receptor dimers. This inverse repeat is conserved in the rat
Ucp3 promoter, and also found slightly more upstream in
the murine promoter albeit in reverse order (Fig. 5C).
Mutational analyses of the Coup-TFII binding element
We further analysed the two repeat elements on oligonu-
cleotide C (Cwt) by disrupting the 5' half (Cmut5'), the 3'
half (Cmut3') or both (Cmut5'3') on bandshift assay
probes (Fig. 6D). We chose to change two bases of the 3'
half-site into adenine and two bases of the inverse 5' half-
site into thymine correspondingly. These probes were
employed either labelled with nuclear extracts of mock or
Coup-TFII transfected cells or unlabelled as competitors
for the interaction of Coup-TFII with element C (Fig. 6A).
All mutated probes displayed a reduced complex forma-
tion with Coup-TFII (Fig. 6B). While probes Cmut5' and
Cmut5'3' did not show any significant complex forma-
tion, probe Cmut3' still formed a complex that was
weaker in intensity and slightly smaller than the wt probe.
In competition assays the mutated competitor oligonucle-
otides were less efficient in competing Coup-TFII complex
formation on the Cwt probe than the unlabelled Cwt oli-
gonucleotide itself (Fig. 6C). Again Cmut5' and Cmut5'3'
generated a similar pattern of no binding of Coup-TFII to
these mutated elements. Mutation Cmut3' did not
entirely loose its ability to compete complex formation,
which is in line with its demonstrated retained capability
of interaction with Coup-TFII.
We introduced the same mutations Cmut5' and Cmut3'
into our reporter gene vector -2244UCP3luc generating -
2244Cmut5'luc and -2244Cmut3'luc (Fig. 7). Disruption
of the 3'half-site on -2244Cmut3'luc did not lower respon-
Disruption of the 5' half-site leads to loss of Coup-TFII bindingFigure 6
Disruption of the 5' half-site leads to loss of Coup-TFII binding. (A) Electrophoretic mobility shift assay with element 
C and mutated derivatives (compare (D)). Bands were quantified, background corrected and analyzed. Probe = labelled oligo-
nucleotide used; comp. = unlabelled competitor oligonucleotide used; CII = nuclear extract of Coup-TFII transfected HEK293 
cells; mock = nuclear extract of mock transfected HEK293 cells. (B) Quantification of complex intensity on labelled probes 
Cwt, Cmut5', Cmut3' and Cmut5'3'. Probe Cmut3' retained a lowered ability to bind Coup-TFII while Cmut5'and 
Cmut5'3'were unable to do so. (C) Accordingly unlabelled competitor probe Cmut3' was still able to partially compete for 
Coup-TFII binding to the labelled wt probe, while Cmut5' and Cmut5'3' were not. (D) Overview of the probes used in electro-
phoretic mobility shift assays. Probe Cwt represents element C, the mutated derivatives are depicted below.Page 8 of 15
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RXRα and p300, but did even proportionally increase
luciferase activity by a small amount. Conversely, -
2244Cmut5'luc was devoid of any luciferase activity in all
conditions tested and displayed a pattern resembling our
empty control vector pGL3 basic.
Discussion
A prominent hypothesis considers uncoupling protein 3
(Ucp3) to be a crucial component of lipid metabolism
with implications for the regulation of body weight and
composition [3]. This role is further substantiated by the
identification of polymorphisms/alleles in the human
Ucp3 gene that are associated with an elevated body mass
index [28]. A more detailed analysis of the machinery reg-
ulating Ucp3 transcription is therefore of importance for
identifying regulatory networks controlling energy parti-
tioning.
Our comparison of previously characterized Ucp3 pro-
moter elements in rat, mouse and human with the ham-
ster sequence, shows full conservation of the binding sites
for MyoD, PPARα/RXRα and TR/RXRα heterodimers. The
sequence alignment furthermore demonstrates that two
TATA-like boxes present in the human promoter [26] are
absent in rodent sequences including the hamster. This
might prove to be crucial considering, that in the study of
Riquet and coworkers (2003) the activities of human con-
structs were investigated in murine tissue.
The TSS of the human Ucp3 gene is quite variable and dis-
plays a distinct tissue specificity, whereas in mouse the
TSS is located at a single site [29]. Our result of variable
TSS in P. sungorus demonstrates that the constancy in
mouse does not reflect a common trait of rodent species.
However, in the hamster the TSS did not show a distinct
tissue specificity as found in humans.
By in silico analysis we identified Coup-TFII as a candidate
transcription factor for the regulation of Ucp3 expression.
Coup-TFII is a 45 kD nuclear orphan receptor and mem-
ber of the COUP-TF family. The amino acid sequence of
the ligand binding and the DNA binding domain is con-
served across species to a very high extent (human vs. Dro-
sophila ~90%) indicating an important role for these
domains. Coup-TFII has mainly been described as a cru-
cial factor in developmental processes [21,22].
By qPCR we measured Ucp3 and Coup-TFII transcript lev-
els in a panel of nine different tissues. We confirmed that
Disruption of the 5' half-site leads to complete loss of activityFigure 7
Disruption of the 5' half-site leads to complete loss of activity. Reporter gene assays with mutated luciferase con-
structs. In the upper panel basal luciferase activity and induction by Coup-TFII is shown, in the lower panel the experiment was 
repeated on a background of MyoD, RXRα and p300. Disruption of the 3' half site on -2244Cmut3'luc did not lower activity in 
any condition tested. Disrupting the 5' half-site on -2244Cmut5'luc led to a complete loss of basal activity and responsiveness to 
Coup-TFII and MyoD, RXRα and p300.Page 9 of 15
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sion. Coup-TFII was detected in both tissues, but in line
with previous data on human adult tissue distribution
[30] is rather ubiquitously expressed with highest levels in
kidney, liver and heart. Contrary to reports that Coup-TFII
is expressed in preadipocytes and myoblasts and down-
regulated during differentiation [23,31], we were able to
detect considerable amounts of Coup-TFII transcript in
BAT and SKM tissue. Apparantely cell culture systems are
devoid of the appropriate physiological stimuli promot-
ing Coup-TFII mRNA expression in tissues. This is sup-
ported by the absence of Coup-TFII in human embryonal
kidney cells as shown in our Western blot experiment
(Fig. 5B) despite its presence in human kidney tissue in
vivo [30]. It has been demonstrated that Coup-TFII plays
an important role in the regulation of several genes encod-
ing key metabolic enzymes [18,23-25], which are cer-
tainly regulated in terminally differentiated cells.
Ucp3 gene expression was upregulated in SKM of food
deprived hamsters. In line with the function of Coup-TFII
in metabolic regulation we also observed a significant
increase of mRNA expression in response to this chal-
lenge. Probably owing to the short duration of cold expo-
sure in our study we did not observe a significant cold
induced increase in Ucp3 mRNA expression in BAT as
published previously [5,6]. However, Coup-TFII and Ucp3
mRNA expression in BAT displayed a similar cold-
induced increase in variation. The resemblance of expres-
sion levels in SKM and BAT and the response to physio-
logical stimuli culminates in a highly significant
correlation of Coup-TFII and Ucp3 mRNA abundancy
under challenged conditions (food deprivation and cold).
The absence of such a correlation in the control group sug-
gests that Coup-TFII requires additional factors in order to
enhance Ucp3 mRNA expression which must be recruited
and/or activated beforehand.
We could support this model in reporter gene assays, in
which Coup-TFII strongly coactivated Ucp3 promotor
activity in synergy with PPARα, MyoD, RXRα and/or
p300, while the effect of Coup-TFII was much lower
alone. These constituents of the well described basal tran-
scription factor complex in our experiments affected Ucp3
expression as described previously [15], i.e. strong activa-
tion by PPARα/RXRα and p300, dependent on agonist
stimulation and presence of MyoD. Coup-TFII specifically
enhanced expression in synergy with these factors.
In contrast to our data, Coup-TFII has been shown to neg-
atively interact with MyoD and p300 in SKM, reducing
their potential to activate E-box driven reporter gene con-
structs [17]. This discrepancy may be explained by a differ-
ential recruitment of the multiple COUP-TF family
cofactors in different physiological environments [e.g. N-
Cor, SMRT, RIP140, SRC-1; for a review see [32]]. The spe-
cific complex of transcription factors, to which Coup-TFII
is recruited, may determine the final function as described
for interaction with the glucocorticoid receptor [33]. In
general, COUP-TF proteins display a conflicting pattern of
positive or negative interaction with nuclear receptors like
PPARs or the estrogen receptor depending on the target
gene [discussed in [18]]. There are genes where transcrip-
tion is increased by PPARs and decreased by COUP-TFs
[e.g. malic enzyme [19]] as well as genes for which the sit-
uation is opposite [e.g. transferrin [20]] or at which both
PPARs and COUP-TFs act synergistically [e.g. lipoprotein
lipase [18]]. Even a complete reversal of the effect of
Coup-TFII on a single target has been reported [23]; tran-
scription of the phosphoenolpyruvate carboxykinase gene
is induced or repressed by Coup-TFII in a tissue specific
manner.
Interestingly, specific PPARγ agonists upregulate Coup-
TFII in the heart [24] and also Ucp3 gene expression in
BAT and SKM [34,35], although to our knowledge no
direct interaction of PPARγ with the Ucp3 promoter has
been verified so far. This effect might therefore be due to
PPARγ mediated transactivation of Coup-TFII, which in
turn enhances Ucp3 expression.
We were able to confine the sequence element mediating
the Coup-TFII effect to -1307 to -664 by utilizing reporter
gene deletion constructs. -2244UCP3luc was the only con-
struct being induced by Coup-TFII on a background of
MyoD, RXRα and p300 and was exclusively activated high
above an unspecific effect by Coup-TFII alone.
Of five candidate elements A-E within this region tested
by electrophoretic mobility shift assays we confirmed spe-
cific binding of Coup-TFII to element C. Notably, element
C did not only show complex formation with overex-
pressed Coup-TFII but also with nuclear extracts of ham-
ster SKM (Fig. 5D). Extracts of all six animals tested were
able to form a complex of comparable size and food dep-
rivation of hamsters led to an increase in band intensity.
The element is located at -816 to -840 and constitutes a
functional repeat structure. By mutational analyses we
were able to confine Coup-TFII binding to the 5' half-site
of this element. In reporter gene assays disruption of this
site surprisingly led to a complete loss of activity and
responsiveness to any treatment tested. While this fact cer-
tainly underlines the importance of this element, its indif-
ference to MyoD, RXRα and p300 treatment is in conflict
with the retained effect of this treatment on -664UCP3luc
and -243UCP3luc, that are also devoid of this element. It
seems that the element exhibits a function beyond direct
transactivation by Coup-TFII, that depends on the pres-
ence of the surrounding region. These characteristics point
towards a model of Coup-TFII deactivating or displacing aPage 10 of 15
(page number not for citation purposes)
BMC Molecular Biology 2007, 8:1 http://www.biomedcentral.com/1471-2199/8/1so far unknown repressor of Ucp3 transcription. This
repressor could be expected to bind in proximity to the 5'
half-site of elementC, possibly even to the 3' half-site of
this same element. In the light of this hypothetical model
several formerly negligible seeming facts gain relevancy:
Mutated construct -2244Cmut3'luc displayed an overall
increase of luciferase activity as compared to -
2244UCP3luc (Fig. 7). Deletion construct -664UCP3luc
had a higher basal activity and could be activated by
MyoD, RXRα and p300 to a higher extent than -
2244UCP3luc (Fig. 4B). The complex size of bandshift
probe Cmut5' was slightly changed (Fig. 6A).
This model alone, however, does not account for the acti-
vation of -2244UCP3luc by MyoD, RXRα, p300 and
PPARα in the absence of cotransfected Coup-TFII. There-
fore there would have to be an endogenous Coup-TFII
expression in HEK293 cells that we can either not detect
with our Western blots or is induced by transfection of fac-
tors like MyoD and p300. At present we cannot decide
wether repressor displacement/deactivation itself or sub-
sequent direct coactivation is the dominant means of
Coup-TFII mediated transcriptional induction.
The conservation of the inverse repeat structure and its
Coup-TFII binding site across rodent species suggests an
important role for this element; its preservation in the
murine promoter despite an obvious event of rearrange-
ment during evolution supports this role. The upstream
location of the binding element and its synergy with
PPARα resembles a comparable situation, where Coup-
TFII directly coactivates the lipoprotein lipase gene in
cooperation with PPAR/RXR heterodimers as described
previously [18]. Notably lipoprotein lipase is a crucial
determinant of fatty acid uptake from circulating triglycer-
ides.
An explanation of the link between increased lipid utiliza-
tion and the recruitment of Coup-TFII in BAT and SKM is
hampered by the lack of knowledge about a specific lig-
and and the posttranslational mechanism of activation. It
is beyond the scope of this study to clarify whether Coup-
TFII is directly regulated in response to FFA levels and thus
possibly conveys FFA-dependent Ucp3 transcription. Our
qPCR data indicate that de novo synthesis of Coup-TFII is
the dominant means of target gene upregulation rather
than ligand binding or posttranslational modification. So
far, transcription of Coup-TFII has been linked to MAP
kinase pathway activity [36] and the presence of ETS fam-
ily transcription factors [37]. Further research is required
to clarify whether these mechanisms represent a link
between lipid utilization and Coup-TFII upregulation.
On the functional level beyond its role in organismic
development Coup-TFII has been assumed to be an inte-
gral part of the glucose response complex, where it func-
tions as an inhibitor of glucose dependent activators [25].
This hypothesis is based on the ability of Coup-TFII to
inhibit upstream stimulatory factor (USF)-dependent
transactivation of a glucose response element in the L-type
pyruvate kinase gene (PKLR) and a similar finding regard-
ing the ATPA gene encoding the alpha subunit of the F1F0
ATP synthase complex [38]. Recently, Bardoux and cow-
orkers (2005), after discovering a role for Coup-TFII in
insulin secretion and sensitivity, assigned Coup-TFII as an
important regulator of glucose homeostasis [39]. Our
finding of Coup-TFII upregulation in states of augmented
lipid oxidation confirms these models and extends them
to a new aspect. The inhibition of glucose induced gene
transcription may occur in conjunction with a positive
regulation of lipid metabolism genes like Ucp3 and lipo-
protein lipase.
Conclusion
Coup-TFII is a strong activator of Ucp3 gene transcription
by binding to an upstream element in the Ucp3 promoter
as shown by luciferase assays and electrophoretic mobility
shift assays. Coup-TFII mRNA expression correlates with
Ucp3 mRNA levels in tissues of hamsters subjected to
physiological challenges inducing lipid oxidation. Tran-
scriptional upregulation of the Coup-TFII gene in response
to these challenges seems to regulate the Ucp3 gene in
brown adipose and skeletal muscle tissue determining the
final appropriate rate of Ucp3 mRNA synthesis. The mech-
anism of Coup-TFII inducing Ucp3 transcription seems to
involve displacement/deactivation of an unknown repres-
sor. These findings add a crucial component to the com-
plex transcriptional machinery controlling expression of
Ucp3. At the same time they further manifest a function of
Coup-TFII in the regulation of lipid metabolism genes.
Methods
Animal experimentation and nucleic acid preparations
Djungarian hamsters (Phodopussungorus) were housed
under standard laboratory conditions with ad libitum
access to food (Hamsterzuchtdiät 7014, Altromin) and
water unless stated otherwise. All experiments involving
animals were conducted in accordance with the German
animal welfare law. For tissue dissections hamsters were
sacrificed by CO2 exposure. Genomic DNA was prepared
from spleen with the DNeasy Tissue Kit (Qiagen). We
either cold exposed hamsters to 4°C ambient temperature
for 24 hours (n = 9) or food deprived hamsters for 48
hours at room temperature (n = 12). A third group of
hamsters was kept at room temperature and fed ad libitum
to serve as control group (n = 12). All hamsters were of an
age of 10 to 15 months. We obtained samples of
suprasternal BAT and hindlimb SKM (Musculus quadri-
ceps) from 9 animals of each group. From three control
group hamsters we also dissected samples of inguinalPage 11 of 15
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Samples were frozen in liquid nitrogen, total RNA pre-
pared with Trizol (Invitrogen) and quantified photomet-
rically. We dissected the entire leg musculature of three
control and starved animals for tissue nuclear protein
extracts.
Primer design, sequencing and sequence analysis
All sequencing reactions were carried out by a commercial
service provider (MWG Biotech). Primer sequences were
selected using the program Primer3 (Code available at
[40]). Primers to amplify fragments of the Ucp3 genomic
locus were deduced from conserved regions of corre-
sponding genomic sequences from the ENSEMBL mouse
and rat genomic databases (ENSMUSG00000032942,
ENSRNOG00000017716), from cDNA sequences of the
putative 5' adjacent gene [GenBank: AU020772,
AI170065] and from P. sungorus Ucp3 cDNA [Genbank:
AF271265]. PCR products were cloned and sequenced.
Assembled contigs were resequenced with homologous
primers and a minimum 5-fold coverage. To analyse the P.
sungorus Ucp3 transcript 2 μg of RNA were reverse tran-
scribed into cDNA with oligo-dT-primers and Superscript
II reagents (Invitrogen). We deduced PCR primers from
the assembled genomic contig to amplify, clone and
sequence two overlapping fragments representing exon1
to exon6 and exon2 to exon7 of the Ucp3 transcript,
respectively. Sequencing results were visualized, edited
and assembled in the GAP4 module of the Staden
Sequence Analysis Package [41]. All sequence alignments
were conducted with ClustalW [42]. Promoter sequences
were analyzed for putative transcription factor binding
sites by considering results obtained with the programs
AliBaba2.1, MATCH™ and PATCH™ [43] all based upon
the TRANSFAC® database [44].
Mapping the transcriptional start site (TSS)
To determine TSS by 5' rapid amplification of cDNA ends
(5' RACE), 1 μg of SKM and BAT total RNA was reverse
transcribed into RACE-ready first-strand cDNA using an
amplification kit (BD SMART RACE, Clontech). We PCR-
amplified the 5'-end with the Ucp3 specific reverse primer
ATGGCTTGAAATCGGACCTTCACCAC combined with
the kit primer mix according to the manual. Products were
cloned into pCR2.1-TOPO (Invitrogen) and independent
clones were picked and sequenced.
Real time qPCR
We cloned a fragment of P. sungorus Coup-TFII [GenBank:
DQ244042] representing parts of exon2 and 3 by deduc-
ing heterologous primers from conserved regions of the
respective mouse and rat transcripts. Nested, homologous
primers were inferred for qPCR analysis. SuperScript® III
Platinum® SYBR® Green Two-Step qRT-PCR Kit (Invitro-
gen) was used to reverse transcribe total RNA prepared as
described above and to measure mRNA expression levels
on an iCycler IQ (Biorad). The PCR Mix was supple-
mented with 20 nM Fluorescein (Biorad). Amplification
efficiency was calculated based on dilution series standard
curves by the Biorad iCycler IQ 3.0 software and used to
determine starting quantity levels (PCR base line sub-




GGGCTTA, TCCAGCAGCTTCTCCTTGAT. Group differ-
ences were tested for significance with the Mann-Whitney
rank sum test, correlations were calculated by the Spear-
man rank order method (SigmaStat 3.1, Systat Software).
Vector origins and construction
Expression vectors pCMV-SPORT6 harbouring the com-
plete coding sequence of human Coup-TFII
(IMAGE:5177487), COUP-TFI (IMAGE:2824138) and
murine MyoD in pME18S-FL (IMAGE:1499265) were
obtained from the "Deutsches Resourcenzentrum für
Genomforschung" (RZPD, Berlin) and verified by
sequencing. Human full length RXRα in pSG5 was kindly
provided by A. Baniahmad (Gießen, Germany), human
p300 in pCMVβ by C. Platzer (Jena, Germany) and human
PPARα in pCMV7 by H. Shimano (Tokyo, Japan).
A region comprising a BamHI fragment from -2244 to +38
of the Ucp3 gene was amplified by Pfu polymerase (Fer-
mentas). It was cloned into a BglII site of pGL3 basic
(Promega) exploiting the endogenous, compatible
BamHI sites to generate -2244Ucp3luc. Subsequently,
three different deletion constructs were cloned (outlined
in Fig. 4B). By restriction with BglII and religation we cre-
ated -2244BglIIdel Ucp3luc, bearing a 1161 bp deletion
from -1307 to -146. The construct -664Ucp3luc was gener-
ated by restriction of -2244Ucp3luc with the compatible
enzymes XbaI and NheI, but owing to a XbaI site in the
vector backbone we applied a partial restriction followed
by gel purification and religation of the appropriate frag-
ment. We constructed -243Ucp3luc by restriction of -
664Ucp3luc with BfrBI and SmaI and religation of the aga-
rose gel purified larger fragment.
For mutational analyses of element C we constructed two
further reporter gene constructs -2244Cmut5'luc and -
2244Cmut3'luc by PCR overlap extension site directed
mutagenesis as described previously [45]. To mutate the
first half-site (Cmut5') we used the overlapping mutated
primers TCAAGGACATTTTCTTCCCA and CCTTGGGAA-
GAAAATGTCCT, to mutate the second half-site (Cmut3')
ACTTCCCAAGGAAACACAGC and GCTGTGTTTCCTT-
GGGAAGT. For both primer pairs we designed the outer
primers TCACTGTTGTCTCTGCTGCC and GCAG-
CAGCCATCCTTAGAAC to produce an amplicon includ-Page 12 of 15
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two resulting mutated fragments were cloned into pGEM-
Teasy (Promega) and sequenced to verify the introduced
mutation. BglII-fragments derived from these vectors were
subcloned into -2244BglIIdel Ucp3luc and again
sequenced to guarantee successful subcloning of the
respective mutated site.
Cell culture and luciferase assays
We utilized the human embryonal kidney cell line
HEK293 as a heterologous system for our reporter gene
studies. Cells were grown in DMEM supplemented with
10% FCS and split every second day. For luciferase assays
cells were detached by trypsin and passaged onto 12 well-
plates. Cells were transfected by the calcium-phosphate
method using the ProFection Kit (Promega). We used 25
ng reporter gene construct, 1.25 ng phRL-tk (Promega),
500 ng for each expression vector and added empty
pcDNA3 (Invitrogen) to a final mass of 2 μg and added
100 μl of precipitate solution per well to the medium. For
every vector combination we prepared three replicate
wells. Cells were incubated with the transfection mixture
for 16 hours, medium was changed and cells harvested 24
hours later. When 10 μM of the PPARα ligand Wy14,643
was applied as a stimulant, it was added in DMSO during
the medium change. In all measurements without stimu-
lant, medium was supplied with the same volume of
DMSO only. Luciferase activity was measured with the
Dual Luciferase Reporter Assay System (Promega). Initial
experiments revealed that cotransfection of cells with vec-
tors driving expression of nuclear receptors systematically
affected phRL-tk activity, a known handicap of this system
[46]. We therefore used primary, unnormalized data for
activity calculations. To validate these data we measured
protein content by the Bradford method and confirmed
that this normalization did not result in values signifi-
cantly different from unnormalized data. All results are
shown as fold changes relative to the basal activity of the
respective construct used.
Electrophoretic mobility shift assay
HEK293 cells were harvested in 200 μl homogenisation
buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5
mM DTT, 20 mM NaF), homogenized in a glass potter
and centrifuged (3300 g, 15 min, 4°C). The pellet was
resuspended in 100 μl low salt buffer (20 mM HEPES, 1.5
mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 20 mM NaF,
25% (v/v) glycerol) and subsequently mixed with 100 μl
high salt buffer (= low salt buffer with 1.2 M KCl). The
mixture was agitated vigorously for 30 min at 4°C and
centrifuged (25,000 g, 30 min, 4°C). The supernatant
containing nuclear proteins was purified with a Microcon
YM-50 column (Millipore), aliquoted and stored at -
80°C. All above mentioned buffers were supplied with
protease inhibitors (Complete Mini Protease Inhibitor
Cocktail Tablet, Roche) and phosphatase inhibitors
(Phosphatase Inhibitor Cocktail II, Sigma). Protein con-
centrations were measured by the Bradford method with
BSA as a standard.
For tissue nuclear extracts we excised the complete leg
musculature of a hamster and grinded it in liquid nitrogen
to yield a fine powder. The powder was treated as
described above with the following modifications. We
used 1 ml homogenisation buffer, washed the pellet in 1
ml homogenisation buffer and subsequently used 200 μl
of high and low salt buffer. We did not employ the con-
centrator column for tissue extracts.
Complementary oligonucleotides were annealed by heat-
ing to 80°C in TE (10 mM Tris/HCl, 1 mM EDTA) and
slow cooling to room temperature. Double strands were
further purified by elution from a 12% polyacrylamide
gel. Three pmol of the resulting doublestrand were endla-
belled with T4 polynucleotide kinase and [γ-32P]ATP and
purified with a ChromaSpin+10-TE column (Clontech).
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For gel retardation assays we incubated 3 μg (HEK293) or
20 μg (tissue) nuclear extract with ~7.5 fmol probe for 20
min on ice in a final volume of 2 μl containing 4% (v/v)
glycerol, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50
mM NaCl, 10 mM Tris/HCl (pH 7.5) and 50 μg/ml
poly(dIdC)·poly(dIdC). Samples were analyzed by elec-
trophoresis in a 5.2% nondenaturing polyacrylamide gel
at 4°C and 200 V for 3 hours in 0.5 × TBE. The gel was
exposed to a phosphoscreen for 18 hours. For competi-
tion assays we included a 2–100 fold molar excess of unla-
belled oligonucleotide in the reaction. For supershift
assays we added 1 μl of Coup-TFII antibody (Santa Cruz,
sc6576-X). The specificity of this antibody and the pres-
ence of Coup-TFII protein in the nuclear fraction of trans-
fected cells was confirmed by Western blot.
Densitometrical quantification of band intensities was
performed with the software ImageJ 1.34s [47]. All values
were background corrected.
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